Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Gwen Skloot MD, ATSF

Gwen Skloot MD, ATSF

Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York

Dr. Gwen Skloot, MD, ATSF is a Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Skloot is the Medical Director of the Pulmonary Physiology Program and has conducted research on airway hyperresponsiveness for the last 25 years.   This parallels her clinical interest in asthma.   Dr. Skloot has done clinical trials research as part of the American Lung Association Asthma Clinical Research Center and has participated in multi-center clinical trials related to therapy for severe asthma and for COPD.   She is the Immediate Past Assembly Chair of the Respiratory Structure & Function Assembly of the American Thoracic Society.

Disclosures

No disclosures reported.

Recent Contributions to PracticeUpdate:

  1. Once-Daily, Single-Inhaler Mometasone-Indacaterol-Glycopyrronium vs Mometasone-Indacaterol or Twice-Daily Fluticasone-Salmeterol for Inadequately Controlled Asthma

Most Read This Week

Recently Updated